Seetharama D. Jois

2.7k total citations
86 papers, 2.0k citations indexed

About

Seetharama D. Jois is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Seetharama D. Jois has authored 86 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 28 papers in Radiology, Nuclear Medicine and Imaging and 21 papers in Oncology. Recurrent topics in Seetharama D. Jois's work include Monoclonal and Polyclonal Antibodies Research (28 papers), Chemical Synthesis and Analysis (16 papers) and HER2/EGFR in Cancer Research (12 papers). Seetharama D. Jois is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (28 papers), Chemical Synthesis and Analysis (16 papers) and HER2/EGFR in Cancer Research (12 papers). Seetharama D. Jois collaborates with scholars based in United States, Singapore and Egypt. Seetharama D. Jois's co-authors include Sitanshu S. Singh, Rushikesh Sable, Teruna J. Siahaan, Achyut Dahal, R. Manjunatha Kini, M. Graça H. Vicente, Konstantin G. Kousoulas, David G. Vander Velde, Usman Sumo Friend Tambunan and Subramanian Vivekanandan and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Seetharama D. Jois

83 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seetharama D. Jois United States 29 1.2k 326 258 248 229 86 2.0k
Vibhudutta Awasthi United States 26 1.0k 0.8× 204 0.6× 152 0.6× 359 1.4× 242 1.1× 100 2.2k
Sheng Wang China 23 836 0.7× 131 0.4× 240 0.9× 235 0.9× 114 0.5× 90 1.6k
Yupeng Li China 23 832 0.7× 330 1.0× 320 1.2× 181 0.7× 85 0.4× 77 1.8k
Xiaoqiu Wu China 24 2.3k 1.9× 524 1.6× 139 0.5× 408 1.6× 200 0.9× 67 3.2k
Heidi Wunderli‐Allenspach Switzerland 33 1.4k 1.2× 801 2.5× 194 0.8× 216 0.9× 139 0.6× 62 2.8k
Carston R. Wagner United States 36 2.6k 2.1× 355 1.1× 655 2.5× 251 1.0× 300 1.3× 129 3.8k
Sotiris Missailidis United Kingdom 24 1.9k 1.6× 196 0.6× 174 0.7× 517 2.1× 293 1.3× 87 2.4k
Guoquan Yan China 32 2.4k 2.0× 309 0.9× 219 0.8× 308 1.2× 221 1.0× 136 3.4k
Tongsheng Chen China 31 1.2k 1.0× 200 0.6× 160 0.6× 628 2.5× 125 0.5× 142 2.6k
Sang J. Chung South Korea 30 1.7k 1.4× 205 0.6× 364 1.4× 403 1.6× 154 0.7× 121 3.0k

Countries citing papers authored by Seetharama D. Jois

Since Specialization
Citations

This map shows the geographic impact of Seetharama D. Jois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seetharama D. Jois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seetharama D. Jois more than expected).

Fields of papers citing papers by Seetharama D. Jois

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seetharama D. Jois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seetharama D. Jois. The network helps show where Seetharama D. Jois may publish in the future.

Co-authorship network of co-authors of Seetharama D. Jois

This figure shows the co-authorship network connecting the top 25 collaborators of Seetharama D. Jois. A scholar is included among the top collaborators of Seetharama D. Jois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seetharama D. Jois. Seetharama D. Jois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayandi, Venkatesh, et al.. (2025). Discrete Brush Polymers Enhance 19F MRI Performance through Architectural Precision. Journal of the American Chemical Society. 147(19). 16171–16178. 2 indexed citations
2.
Jois, Seetharama D., et al.. (2025). Molecular Chimera in Cancer Drug Discovery: Beyond Antibody Therapy, Designing Grafted Stable Peptides Targeting Cancer. International Journal of Peptide Research and Therapeutics. 31(3). 38–38.
3.
Dahal, Achyut, Xin Gu, William D. Johnson, et al.. (2023). Lyophilized liposomal formulation of a peptidomimetic-Dox conjugate for HER2 positive breast and lung cancer. International Journal of Pharmaceutics. 639. 122950–122950. 7 indexed citations
4.
5.
Musarrat, Farhana, et al.. (2022). Predicted Structure and Functions of the Prototypic Alphaherpesvirus Herpes Simplex Virus Type-1 UL37 Tegument Protein. Viruses. 14(10). 2189–2189. 5 indexed citations
6.
Dahal, Achyut, et al.. (2022). 1,3‐diarylpyrazolones as potential anticancer agents for non‐small cell lung cancer: Synthesis and antiproliferative activity evaluation. Chemical Biology & Drug Design. 99(4). 620–633. 7 indexed citations
7.
Dahal, Achyut, et al.. (2022). Targeting protein–protein interaction for immunomodulation: A sunflower trypsin inhibitor analog peptidomimetic suppresses RA progression in CIA model. Journal of Pharmacological Sciences. 149(3). 124–138. 2 indexed citations
8.
Jois, Seetharama D., et al.. (2022). Multiple primary lung cancer tumours with diversified genetic mutations‐complications in choosing therapeutic options. SHILAP Revista de lepidopterología. 2(3).
9.
Jois, Seetharama D., et al.. (2021). Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer. International Journal of Molecular Sciences. 22(2). 779–779. 65 indexed citations
10.
Dahal, Achyut, et al.. (2021). Peptides and peptidomimetics as therapeutic agents for Covid‐19. Peptide Science. 114(1). e24245–e24245. 12 indexed citations
11.
Dahal, Achyut, Sitanshu S. Singh, Samy M. Ibrahim, et al.. (2021). Quinazoline‐tethered hydrazone: A versatile scaffold toward dual anti‐TB and EGFR inhibition activities in NSCLC. Archiv der Pharmazie. 354(12). e2100281–e2100281. 10 indexed citations
12.
Zhou, Zehua, et al.. (2020). Targeting EGFR Overexpression at the Surface of Colorectal Cancer Cells by Exploiting Amidated BODIPY‐Peptide Conjugates. Photochemistry and Photobiology. 96(3). 581–595. 8 indexed citations
13.
Sable, Rushikesh, et al.. (2020). Modulation of co‐stimulatory signal from CD2–CD58 proteins by a grafted peptide. Chemical Biology & Drug Design. 97(3). 607–627. 4 indexed citations
14.
Singh, Sitanshu S., Achyut Dahal, George Mattheolabakis, et al.. (2020). In vivo studies of a peptidomimetic that targets EGFR dimerization in NSCLC. Journal of Cancer. 11(20). 5982–5999. 4 indexed citations
15.
Singh, Sitanshu S., et al.. (2019). Genotype Driven Therapy for Non-Small Cell Lung Cancer: Resistance, Pan Inhibitors and Immunotherapy. Current Medicinal Chemistry. 27(32). 5274–5316. 33 indexed citations
16.
Singh, Sitanshu S., et al.. (2018). Design of cyclic and d‐amino acids containing peptidomimetics for inhibition of protein‐protein interactions of HER2‐HER3. Journal of Peptide Science. 24(2). 11 indexed citations
17.
Sable, Rushikesh, et al.. (2017). Peptide ligands for targeting the extracellular domain of EGFR: Comparison between linear and cyclic peptides. Chemical Biology & Drug Design. 91(2). 605–619. 25 indexed citations
18.
Gokhale, Ameya, Rushikesh Sable, Jason D. Walker, et al.. (2015). Inhibition of cell adhesion and immune responses in the mouse model of collagen‐induced arthritis with a peptidomimetic that blocks CD2‐CD58 interface interactions. Biopolymers. 104(6). 733–742. 9 indexed citations
19.
Gokhale, Ameya, et al.. (2014). Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2‐Positive Breast Cancer. Chemical Biology & Drug Design. 85(6). 702–714. 18 indexed citations
20.
Sinaga, Ernawati, Seetharama D. Jois, Irwan T. Makagiansar, et al.. (2002). Increasing Paracellular Porosity by E-Cadherin Peptides: Discovery of Bulge and Groove Regions in the EC1-Domain of E-Cadherin. Pharmaceutical Research. 19(8). 1170–1179. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vibhudutta Awasthi Breakdown of academic impact, for papers by Sheng Wang Breakdown of academic impact, for papers by Yupeng Li Breakdown of academic impact, for papers by Xiaoqiu Wu Breakdown of academic impact, for papers by Heidi Wunderli‐Allenspach Breakdown of academic impact, for papers by Carston R. Wagner Breakdown of academic impact, for papers by Sotiris Missailidis Breakdown of academic impact, for papers by Guoquan Yan Breakdown of academic impact, for papers by Tongsheng Chen Breakdown of academic impact, for papers by Sang J. Chung
Rankless by CCL
2026